Search Results - "Younis, T"

Refine Results
  1. 1

    Cost-effectiveness of febrile neutropenia prevention with primary versus secondary G-CSF prophylaxis for adjuvant chemotherapy in breast cancer: a systematic review by Younis, T., Rayson, D., Jovanovic, S., Skedgel, C.

    Published in Breast cancer research and treatment (01-10-2016)
    “…The adoption of primary (PP) versus secondary prophylaxis (SP) of febrile neutropenia (FN), with granulocyte colony-stimulating factors (G-CSF), for adjuvant…”
    Get full text
    Journal Article
  2. 2

    Extraction of chitin from edible crab shells of Callinectes sapidus and comparison with market purchased chitin by Jabeen, F., Younis, T., Sidra, S., Muneer, B., Nasreen, Z., Saleh, F., Mumtaz, S., Saeed, R. F., Abbas, A. S.

    Published in Brazilian journal of biology (2023)
    “…Abstract Chitin and its derived products have immense economic value due to their vital role in various biological activities as well as biomedical and…”
    Get full text
    Journal Article
  3. 3

    Efficacy of Citrullus colocynthis seed extract on Earias vittella, Fabricius, (Lepidoptera: Noctuidae): environment sustainable approach by Hassam, U A, Gulzar, A, Rasool, B, Zafar, S, Younis, T, Shakeel, M, Khan, D, Ullah, S, Khaliq, S, Ahmad, S F, Hafeez, M

    Published in Brazilian journal of biology (2024)
    “…Earias vittellaFabricius, 1794 (Noctuidae: Lepidoptera) is deliberated to be one of the most destructive pests of cotton and okra vegetation in the world…”
    Get full text
    Journal Article
  4. 4

    Nasopharyngoscopic Evaluation of Velopharyngeal Closure During Speech by Slavin, Blaire V, Mirsky, Nicholas A, Paolucci, Nicholas M, Nayak, Vasudev Vivekanand, T Younis, Ramzi, Coelho, Paulo G, Thaller, Seth R

    Published in The Journal of craniofacial surgery (10-05-2024)
    “…Definitive oronasal separation through closure of the velopharyngeal (VP) sphincter is necessary for the development of normal speech and feeding. Individuals…”
    Get full text
    Journal Article
  5. 5

    Monitoring of Insecticides resistance against cotton Jassid (Amrasca biguttutla biguttutla) under laboratory conditions by Javed, Z., Asim, M. S., Ishaq, A. R., Younis, T., Manzoor, M., Hussain, D., Ejaz, M., Saleem, U., Asrar, M.

    Published in Brazilian journal of biology (2023)
    “…Abstract Development of insecticides resistance mainly hinge with managements techniques for the control of Jassid, Amrasca biguttutla biguttutla. Five…”
    Get full text
    Journal Article
  6. 6

    Oncology education for internal medicine residents: a call for action by Younis, T, Colwell, B

    Published in Current oncology (Toronto) (01-06-2018)
    “…Cancer is a prevalent health condition that all physicians will frequently encounter during their clinical practice. [...]…”
    Get full text
    Journal Article
  7. 7

    The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency by de Armas, Lesley R, Gavegnano, Christina, Pallikkuth, Suresh, Rinaldi, Stefano, Pan, Li, Battivelli, Emilie, Verdin, Eric, Younis, Ramzi T, Pahwa, Rajendra, Williams, Siôn L, Schinazi, Raymond F, Pahwa, Savita

    Published in Frontiers in immunology (31-08-2021)
    “…HIV eradication is hindered by the existence of latent HIV reservoirs in CD4 T cells. Therapeutic strategies targeting latent cells are required to achieve a…”
    Get full text
    Journal Article
  8. 8

    Timeliness of the oncology drug review process for public funding in Canada by Younis, T, Skedgel, C

    Published in Current oncology (Toronto) (01-10-2017)
    “…The oncology drug review process for public funding in Canada (Figure 1) encompasses both. [...]…”
    Get full text
    Journal Article
  9. 9

    A Single-Sensor-Based Circulating Current Controller for a Modified Three-level Modular Multilevel Converter by Younis, T., Mattavelli, P., Toigo, I., Corradin, M.

    “…A voltage controller for the middle capacitor of a modified modular multilevel converter (MMC) is proposed in this paper. This controller is utilized as an…”
    Get full text
    Conference Proceeding
  10. 10

    Is adjuvant trastuzumab a cost-effective therapy for HER-2/neu-positive T1bN0 breast cancer? by Skedgel, C., Rayson, D., Younis, T.

    Published in Annals of oncology (01-07-2013)
    “…In light of clinical uncertainty and the high acquisition costs of trastuzumab, we examined the value for money associated with concurrent or sequential…”
    Get full text
    Journal Article
  11. 11

    The effect of light curing time and intensity on the bond strength and fracture resistance of orthodontic adhesive by Mohammed, Omar K., Younis, Mohammed T., Dawood, Alaa E.

    “…Background. This study aimed to measure the shear bond strength and compressive strength of orthodontic adhesives at different curing times and intensities…”
    Get full text
    Journal Article
  12. 12

    The politicization of oncology drug funding reviews in Canada by Skedgel, C, Younis, T

    Published in Current oncology (Toronto) (01-06-2016)
    “…An article in this issue by Srikanthan, [...]…”
    Get full text
    Journal Article
  13. 13

    Palliative care consultation and aggressive care at end of life in unresectable pancreatic cancer by Lees, C, Weerasinghe, S, Lamond, N, Younis, T, Ramjeesingh, R

    Published in Current oncology (Toronto) (01-02-2019)
    “…Palliative care (pc) consultation has been associated with less aggressive care at end of life in a number of malignancies, but the effect of the consultation…”
    Get full text
    Journal Article
  14. 14

    Economic evaluation of adjuvant trastuzumab emtansine in patients with HER2-positive early breast cancer and residual invasive disease after neoadjuvant taxane and trastuzumab-based treatment in Canada by Younis, T, Lee, A, Coombes, M E, Bouganim, N, Becker, D, Revil, C, Jhuti, G S

    Published in Current oncology (Toronto) (01-12-2020)
    “…In the katherine trial, adjuvant trastuzumab emtansine [T-DM1, Kadcyla (Genentech, South San Francisco, CA, U.S.A.)], compared with trastuzumab, significantly…”
    Get full text
    Journal Article
  15. 15

    Interactions of Nanosized Aggregates of Fullerene C 60 with Electrolytes in Methanol: Coagulation and Overcharging of Particles by Mchedlov-Petrossyan, Nikolay O, Al-Shuuchi, Younis T M, Kamneva, Nika N, Marynin, Andriy I, Klochkov, Vladimir K

    Published in Langmuir (04-10-2016)
    “…Contrary to numerous studies on the stability of fullerene aqueous colloidal solutions in the presence of electrolytes, the corresponding issue for the…”
    Get full text
    Journal Article
  16. 16

    The effect of substitution of sodium chloride with potassium chloride on the physicochemical, microbiological, and sensory properties of Halloumi cheese by Kamleh, R, Olabi, A, Toufeili, I, Najm, N E O, Younis, T, Ajib, R

    Published in Journal of dairy science (01-03-2012)
    “…This study investigated the effect of salt reduction and partial replacement with KCl on the microbiological and sensory characteristics of fresh and matured…”
    Get more information
    Journal Article
  17. 17

    Evidence in medicine: math versus biology by Younis, T, Thana, M, Skedgel, C

    Published in Current oncology (Toronto) (01-12-2017)
    “…The drive for optimal clinical decisions based on "best" evidence has gained significant momentum in the last few decades. [...]…”
    Get full text
    Journal Article
  18. 18

    Interactions of Nanosized Aggregates of Fullerene C60 with Electrolytes in Methanol: Coagulation and Overcharging of Particles by Mchedlov-Petrossyan, Nikolay O, Al-Shuuchi, Younis T. M, Kamneva, Nika N, Marynin, Andriy I, Klochkov, Vladimir K

    Published in Langmuir (04-10-2016)
    “…Contrary to numerous studies on the stability of fullerene aqueous colloidal solutions in the presence of electrolytes, the corresponding issue for the…”
    Get full text
    Journal Article
  19. 19

    Guideposts for quests in the realm of oncology careers by Snow, S, Younis, T

    Published in Current oncology (Toronto) (01-04-2016)
    “…Oncology is a small world in Canada, but the practice each individual undertakes is unique. [...]…”
    Get full text
    Journal Article
  20. 20

    The value-for-money of adjuvant aromatase inhibitors: time to put the debate to rest? by Younis, T, Groom, A

    Published in Current oncology (Toronto) (01-04-2015)
    “…The adoption of costly treatments in public health care systems, such as exists in Canada, must take into account their “clinical benefit to side effect”…”
    Get full text
    Journal Article